AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

(Reuters) -AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as ...

In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

The government must urgently abolish stamp duty on shares and abolish new cash ISAs to prevent the London Stock Exchange ...

AstraZeneca, Britain's most valuable public company and responsible for one of the Covid vaccines, reportedly wants to move ...

Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.